Kjell Olmarker
Corporate Officer/Principal bij University of Gothenburg
Profiel
Kjell Olmarker was the founder of PharmaSurgics In Sweden AB, founded in 2005, where he held the title of Director from 2005 to 2009, and Stayble Therapeutics AB, founded in 2015, where he held the title of Director.
Currently, Dr. Olmarker is a Professor at the University of Gothenburg.
Actieve functies van Kjell Olmarker
| Bedrijven | Functie | Begin |
|---|---|---|
| University of Gothenburg | Corporate Officer/Principal | - |
Eerdere bekende functies van Kjell Olmarker
| Bedrijven | Functie | Einde |
|---|---|---|
| STAYBLE THERAPEUTICS AB | Oprichter | - |
PharmaSurgics In Sweden AB
 PharmaSurgics In Sweden AB Pharmaceuticals: MajorHealth Technology PharmaSurgics is a clinical stage biotech company developing novel treatments for the prevention of harmful scarring (adhesions) after surgery. Post-surgical adhesions develop in millions of patients every year and are a source of great patient suffering and enormous healthcare expenditures. The company was founded in 2005 after extensive research done by Dr Inger Mattsby-Baltzer, PhD and Professor Kjell Olmarker MD, PhD at the Sahlgrenska Academy. PharmaSurgics is based in Göteborg, Sweden, where comprehensive in vitro and in vivo facilities have been established. | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| STAYBLE THERAPEUTICS AB | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
PharmaSurgics In Sweden AB
PharmaSurgics In Sweden AB Pharmaceuticals: MajorHealth Technology PharmaSurgics is a clinical stage biotech company developing novel treatments for the prevention of harmful scarring (adhesions) after surgery. Post-surgical adhesions develop in millions of patients every year and are a source of great patient suffering and enormous healthcare expenditures. The company was founded in 2005 after extensive research done by Dr Inger Mattsby-Baltzer, PhD and Professor Kjell Olmarker MD, PhD at the Sahlgrenska Academy. PharmaSurgics is based in Göteborg, Sweden, where comprehensive in vitro and in vivo facilities have been established. | Health Technology |
